Overcoming Oncogenic Mediated Tumor Immunity in Prostate Cancer

Immunotherapy is being tested intensively in clinical trials for prostate cancer; it includes immune checkpoint inhibition, prostate specific antigen (PSA) vaccines and dendritic cell-based strategies. Despite increasing evidence for clinical responses, the consensus of multiple trials is that prost...

Descripción completa

Detalles Bibliográficos
Autores principales: Bryant, Geoffrey, Wang, Lin, Mulholland, David J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5536030/
https://www.ncbi.nlm.nih.gov/pubmed/28714919
http://dx.doi.org/10.3390/ijms18071542

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5536030/
https://www.ncbi.nlm.nih.gov/pubmed/28714919
http://dx.doi.org/10.3390/ijms18071542

Ejemplares similares